Bpr-6023021 For
Metastatic Solid Tumors
Chengdu Syncor Pharmaceutical Co., Ltd.Phase 1/2
—
Rating in progress
Bpr-6023021 For in Metastatic Solid Tumors is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active